Various studies have been conducted on the treatment and management of colorectal cancer, including the use of adjuvant chemotherapy, follow-up strategies, and the use of artificial intelligence for predicting outcomes. Studies have also explored the use of plasma cell-free DNA analysis and tumor microsatellite-instability status as predictors of treatment benefit in colon cancer patients.